Delivery Order SPE2DB22D3004-SPE2DB25FRD52
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Relpax 20 mg tablets (unit dose, 6-count packages) with a ceiling value of $1,617.64. The order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery under a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $642.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 mg RELPAX tablets. The order is for a quantity of six packages of the medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 25, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands. This small order for a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,603.58 firm fixed price delivery order is for the supply of RELPAX 40 MG TABLET UD 12S, a prescription medication, to support military healthcare programs. The award has an ultimate completion date of February 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product RELPAX 40 MG TABLET UD 6S, with a ceiling value of $5,108.83 and a period of performance through March 27, 2024. This delivery order is placed against an indefinite delivery contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,288.32, is for the delivery of the prescription medication RELPAX 20 MG TABLET UD 6S. The contract has an ultimate completion date of January 29, 2025 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of RELPAX 40 MG TABLET UD 6S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $2,070.68 and an ultimate completion date of January 31, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order valued at $8,573.76 to AmerisourceBergen Drug Corp for the supply of Eletriptan HBr 40 mg tablets in unit-dose packages of six. The contract, awarded on November 25, 2025, with an ultimate completion date of November 26, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Eletriptan HBr 40 mg tablet unit dose packs (6s) with a ceiling value of $1,000.83. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,218.11 to AmerisourceBergen Drug Corp for the supply of Eletriptan HBR 40 mg tablets in unit dose packaging (6 tablets per package). This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing under a delivery order contract type. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eletriptan HBR 40 mg tablets in unit dose packaging on November 25, 2025. This competitively awarded, firm fixed-price contract has a ceiling value of $1,747.36 and is scheduled for completion by November 26, 2025. The award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRD52Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,567.79 to AmerisourceBergen Drug Corp for the supply of Relpax 40 mg tablets in unit dose packaging (6 count). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle extending through December 2026 that supports military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Relpax, a migraine treatment medication, represents a typical pharmaceutical commodity within the company's federal supply operations, further supporting military medical readiness and personnel healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/20/25 |